Search

Search Constraints

You searched for: Author/Creator Halimi, Jean‐Michel

Search Results

1. Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? experience of the French thrombotic microangiopathies reference center. Issue 6 (June 2015)

2. CMV‐infected kidney grafts drive the expansion of blood‐borne CMV‐specific T cells restricted by shared class I HLA molecules via presentation on donor cells. Issue 8 (3rd March 2018)

3. Effect of blood pressure variability in the randomized controlled BP TARGET trial. (17th December 2021)

4. Effectiveness of a multicomponent pharmacist intervention at hospital discharge for drug‐related problems: A cluster randomised cross‐over trial. Issue 12 (7th June 2020)

5. Feasibility and safety of tailored dosing schedule for eculizumab based on therapeutic drug monitoring: Lessons from a prospective multicentric study. Issue 5 (7th December 2020)

6. Immune‐mediated thrombotic thrombocytopenic purpura prognosis is affected by blood pressure. Issue 4 (18th May 2022)

7. Increased risk of rejection after basiliximab induction in sensitized kidney transplant recipients without pre‐existing donor‐specific antibodies – a retrospective study. (12th April 2019)

9. Prevention of parvovirus B19‐induced repetitive acute kidney failure by subcutaneous immunoglobulins. (12th November 2019)

10. Risk factors for impaired CD4+ T‐cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantation. (27th December 2013)